LSL Pharma Group Balance Sheet

Financials in millions CAD. Fiscal year is January - December.

Millions CAD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2023	FY 2022	FY 2021	FY 2020	FY 2020
Period Ending	Sep '24 Sep 29, 2024	Dec '23 Dec 30, 2023	Dec '22 Dec 30, 2022	Dec '21 Dec 30, 2021	Dec '20 Dec 30, 2020	Oct '20 Oct 2, 2020
Cash & Equivalents	0.16	0.01	-	0.74	1.93	0.46
Cash & Short-Term Investments	0.16	0.01	-	0.74	1.93	0.46
Cash Growth	-	-	-	-61.52%	316.66%	-
Accounts Receivable	3.39	2.55	0.97	1.12	2.22	1.55
Other Receivables	-	0.13	0.07	0.22	0.19	0.11
Receivables	3.39	2.68	1.04	1.33	2.4	1.66
Inventory	5.63	4.11	2.96	4.17	2.13	1.64
Prepaid Expenses	0.69	0.41	0.21	0.13	0.05	0.16
Other Current Assets	-	-	0.19	0.11	-	-
Total Current Assets	9.87	7.2	4.4	6.48	6.51	3.92
Property, Plant & Equipment	18.93	14.75	13.92	12.89	10.3	9.6
Other Intangible Assets	9.14	8.93	8.98	9.39	9.81	9.91
Long-Term Deferred Tax Assets	-	-	-	-	0.1	0.15
Other Long-Term Assets	0.02	0.02	0.02	0.28	0.46	0.21
Total Assets	37.96	30.9	27.31	29.03	27.18	23.79
Accounts Payable	3.51	4.92	4.54	2.54	2.47	2.47
Accrued Expenses	-	1.06	1.58	1.17	1.64	1.24
Short-Term Debt	0.51	3.77	2.91	-	-	-
Current Portion of Long-Term Debt	4.18	5.22	1.58	1.89	6.03	5.83
Current Portion of Leases	0.26	0.12	0.14	0.19	0.24	0.25
Current Unearned Revenue	-	-	0.01	-	0.51	0.85
Other Current Liabilities	-	-	0.87	1.46	1.66	1.18
Total Current Liabilities	8.46	15.07	11.62	7.25	12.55	11.81
Long-Term Debt	6.52	4.73	7.84	7.98	3.36	3.51
Long-Term Leases	2.57	2.44	2.56	2.69	0.94	0.98
Total Liabilities	17.59	22.25	22.02	17.92	16.84	16.31
Common Stock	36.68	24.2	15.05	12.81	10.26	7.56
Additional Paid-In Capital	2.73	2.32	-	-	-	-
Retained Earnings	-19.42	-18.23	-9.76	-1.7	0.08	-0.08
Comprehensive Income & Other	0.38	0.38	-	-	-	-
Shareholders' Equity	20.37	8.66	5.29	11.11	10.34	7.48
Total Liabilities & Equity	37.96	30.9	27.31	29.03	27.18	23.79
Total Debt	14.04	16.27	15.03	12.74	10.57	10.57
Net Cash (Debt)	-13.88	-16.26	-15.03	-12	-8.64	-10.11
Net Cash Per Share	-0.14	-0.20	-0.23	-0.20	-0.16	-0.21
Filing Date Shares Outstanding	115.53	82.44	68.09	62.66	54.89	47.78
Total Common Shares Outstanding	115.53	82.44	68.09	62.66	54.89	47.78
Working Capital	1.41	-7.87	-7.22	-0.78	-6.04	-7.9
Book Value Per Share	0.18	0.10	0.08	0.18	0.19	0.16
Tangible Book Value	11.23	-0.28	-3.69	1.72	0.54	-2.43
Tangible Book Value Per Share	0.10	-0.00	-0.05	0.03	0.01	-0.05
Land	-	0.28	0.28	0.28	0.28	0.28
Buildings	-	3.97	3.91	3.63	3.51	3.46
Machinery	-	6.02	5.55	5.33	4.73	4.6
Construction In Progress	-	-	1.77	0.47	-	-
Leasehold Improvements	-	3.71	0.93	0.93	0.82	0.17

Source: S&P Capital IQ. Standard template. Financial Sources.